Prof. Ch.V. Rao

Prof. Ch. V. Rao

Florida International University, USA



1969 Ph.D., Washington State University, USA

1966 M.Sc., Washington State University, USA

1964 B.V.Sc., Andhra Veterinary College, India

Publications (selected)

  1. Sukhova-O’ Hare GK, Shah ZA, Lei ZM, Nozdrachev AD, Rao CV, Gozal D (2008) Erectile dysfunction in a murine model of sleep apnea. Am J Respir Crit Care Med, 178: 644-650.
  2. Rask E, Schvarcz E, Hellman P, Hennings J, Karlsson A, Rao CV (2009) ACTH – independent Cushing’s syndrome in pregnancy related to overexpression of adrenal LH/hCG receptors. J Endocrinol Invest, 33: 313-316.
  3. Rahman N, Rao CV (2009) Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research. Mol Human Reprod, 15: 703-711.
  4. Lin J, Li X, Yuan FP, Lin L, Rao CV, Cook CL, Lei ZM (2010) Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol, 69: 253-261
  5. Yuan FP, Li X, Lin J, Schwabe C, Bullesbach EE, Rao CV, Lei ZM (2010) The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction, 139: 759-769.
  6. Rao CV (2010) Human adrenal LH/hCG receptors and what they could mean for adrenal physiology and pathology. Mol Cell Endocrinol, 329: 33-36.
  7. Yu Y, Yuan FP, Li X, Lin D, Lan Z, Rao CV, Lei ZM (2010) Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice. Hormones and Cancer, 5: 256-264.
  8. Morris LF, Park S, Daskivich T, Churchill BM, Rao CV, Lei ZM, Martinez DS, Yeh MW (2011) Virilization of female infant by a maternal adrenocortical carcinoma. Endocrine Practice, 17: e26-e31.
  9. Bourdiec A, Shao R, Rao CV, Akoum A (2012) Human chorionic gonadaotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to Interleukin-1. A new possible mechanism underlying implantation. Biol Reprod, 87: 1-10.
  10. Bourdiec A, Bedard D, Rao CV, Akoum A (2013) Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and release of angiofenic factors. Am J Reprod Immunol, 70: 127-138.
  11. Bourdiec A, Calvo E, Rao CV, Akoum A (2013) Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin. Possible involvement in early embryo implantation. PLoS One, 8: e64829, 1-18.
  12. Rao CV (2014) Uphill battle on the paradigm shift on the targets of human chorionic gonadotropin/luteinizing hormone actions. An editorial. Enliven: Gynecol Obstet, 1 (1) e001.
  13. Rao CV (2014) Uphill battle: The saga of hCG research that led to paradigm shift. Ind J Med Res, (Suppl.) 140: 3-5.
  14. Rao CV, Ticconi C (2015) Why does human chorionic gonadotropin have such a broad regulatory roles in the body and are they totally unexpected? J Reprod Health and Med, 1: 1-3.
  15. Rao CV (2014) Potential therapy of HIV/AIDS and Ebola outbreak with pregnancy hormone, Human chorionic gonadotropin. HIV/AIDS Res Treat Open J, 1 (1): e002.
  16. Rao CV (2015) How and why do gestational trophoblastic neoplasms overproduce human chorionic gonadotropin? Open J Obstet Gynecol, 5: 1-5. DOI:,2015.51001
  17. Parkash J, Lei ZM, Rao CV (2015) The presence of human chorionic gonadotropin/luteinizing hormone receptors in pancreatic ß cells. J Reprod Sci, in press.
  18. Rao CV (2015) It is time to evaluate human chorionic gonadotropin for the treatment of preterm births. Editorial. Women’s Health-Open Journal, 1(1) e3-e4.
  19. Rao CV (2015) Potential therapy for Neisseria Gonorrhoeae infections with human chorionoc Gonadotropin. Reprod Sci, in press.
  20. Rao CV (2015) Potential therapy for rheumatoid arthritis and Sjogren’s syndrome with human chorionic gonadotropin. Reprod Sci, in press.
  21. Rao CV (2015) There is no turning back on the paradigm shift on the actions of human chorionic gonadotropin and luteinizing hormone. J Reprod Health and Med, in press.